P21675 | SWISS-MODEL Repository

The given sequence checksum does not match our current record for P21675!

P21675 (TAF1_HUMAN) Homo sapiens (Human)

Transcription initiation factor TFIID subunit 1 UniProtKB InterPro STRING Interactive Modelling

1893 aa; Sequence (Fasta) ; (Isoform 1; Isoform 13; Isoform 14; Isoform 15; Isoform 16; Isoform 17; Isoform 18; Isoform 19; Isoform 20; Isoform 21; Isoform 22; Isoform 23; Isoform 24; Isoform 25)

It is possible new templates exist for this target since these models were created.

Available Structures

60 Experimental Structures

Description	PDB ID	Oligo-state	Range	Ligands
Human TFIID canonical state	6mzl SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	36-1104
Assess
TFIID lobe C subcomplex	7egh SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer P49848; Q15545; Q6P1X5; Q7Z7C8;	354-1263
Assess
SCP promoter-bound TFIID-TFIIA in post TBP-loading state	7egj SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1263
Assess
SCP promoter-bound TFIID-TFIIA in initial TBP-loading state	7egd SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1263
Assess
Structure of transcribing complex 3 (TC3), the initially transcribing complex with Pol II positione…	8wal SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×W0F; 1×MG;
Assess
Structure of transcribing complex 6 (TC6), the initially transcribing complex with Pol II positione…	8wap SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG; 1×W0F;
Assess
TFIID-based holo PIC on SCP promoter	7egb SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG;
Assess
Structure of transcribing complex 9 (TC9), the initially transcribing complex with Pol II positione…	8was SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG; 1×W0F;
Assess
Structure of transcribing complex 4 (TC4), the initially transcribing complex with Pol II positione…	8wan SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG; 1×W0F;
Assess
Structure of transcribing complex 7 (TC7), the initially transcribing complex with Pol II positione…	8waq SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG; 1×W0F;
Assess
Structure of transcribing complex 5 (TC5), the initially transcribing complex with Pol II positione…	8wao SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG; 1×W0F;
Assess
Structure of transcribing complex 2 (TC2), the initially transcribing complex with Pol II positione…	8wak SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×W0F; 1×MG;
Assess
Structure of transcribing complex 8 (TC8), the initially transcribing complex with Pol II positione…	8war SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A493TD97; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; A0A8D1DPV6; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P29083; P29084; P32780; P35269; P49848; P51948; P52655; P52657; P60899; P85421; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	354-1226	17×ZN; 1×SF4; 1×MG; 1×W0F;
Assess
TFIID-based intermediate PIC on SCP promoter	7eg9 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226	10×ZN; 1×MG;
Assess
TFIID-based intermediate PIC on PUMA promoter	7ega SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P29083; P29084; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226	10×ZN; 1×MG;
Assess
TFIID in rearranged conformation	7egi SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226
Assess
p53-bound TFIID-based holo PIC on HDM2 promoter	7egc SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A481BYI6; A0A4X1TRS6; A0A4X1TVZ5; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VTX4; F1RKE4; I3LCB2; I3LCH3; O00268; P13984; P18074; P19447; P20226; P24928; P29083; P29084; P32780; P35269; P49848; P50613; P51946; P51948; P52655; P52657; P60899; Q00403; Q12962; Q13888; Q13889; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q6ZYL4; Q7Z7C8; Q92759;	362-1226	16×ZN; 1×SF4; 1×MG;
Assess
TFIID in canonical conformation	7ege SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226
Assess
p53-bound TFIID-based core PIC on HDM2 promoter	7edx SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226	9×ZN; 1×MG;
Assess
TFIID-based core PIC on SCP promoter	7eg7 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226	9×ZN; 1×MG;
Assess
TFIID-based core PIC on PUMA promoter	7eg8 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A4X1VYD0; A0A7M4DUC2; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; O00268; P13984; P20226; P35269; P49848; P52655; P52657; P60899; Q00403; Q12962; Q15542; Q15543; Q15544; Q15545; Q16514; Q16594; Q5VWG9; Q6P1X5; Q7Z7C8;	362-1226	9×ZN; 1×MG;
Assess
Crystal Structure of a TAF1-TAF7 Complex in Human Transcription Factor IID	4rgw SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15545;	609-1109	2×GOL;
Assess
Structure of human TFIID-IIA bound to core promoter DNA	5fur SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer P20226; P49848; P52655; P52657; Q15545; Q6P1X5; Q7Z7C8;	609-1109
Assess
Human TFIID bound to promoter DNA and TFIIA	6mzm SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; P52655; P52657; Q12962; Q15542; Q15545; Q16514; Q16594; Q6P1X5; Q7Z7C8;	609-1104
Assess
Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modification…	3aad SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q9Y294;	1374-1649	1×SO4;
Assess
Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide	4yym SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer P62805;	1521-1653	1×CA;
Assess
Crystal structure of TAF1 BD2 Bromodomain bound to a crotonyllysine peptide	4yyn SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer P62805;	1522-1651
Assess
Human TFIID Lobe A canonical	6mzd SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer O00268; P20226; P49848; Q12962; Q15542; Q15543; Q15544; Q16514; Q16594; Q5VWG9;	36-119
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to PLK1 kinase inhibitor BI25…	7k0u SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	1522-1649	4×R78;
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to dioxane	7k42 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	1522-1642	2×SO4; 2×DIO; 22×EDO;
Assess
Crystal structure of the unliganded second bromodomain (BD2) of human TAF1	7k3o SMTL PDBe PDBe-KB PDBj PDBsum RCSB	homo-2-mer	1522-1642	2×SO4; 14×EDO;
Assess
CRYSTAL STRUCTURE OF THE DOUBLE BROMODOMAIN MODULE FROM HUMAN TAFII250	1eqf SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1380-1646	1×SO4;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to GNE-371	7l6x SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1400-1655	1×G9V; 2×EDO;
Assess
Crystal Structure of the tandem bromodomains of human Transcription initiation factor TFIID subunit…	3uv5 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1398-1652	1×TRS;
Assess
Crystal structure of the unliganded tandem bromodomain (BD1, BD2) of human TAF1	7jjh SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1399-1651	7×EDO;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 in complex with MES (2-(N-morp…	7k6f SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1399-1650	1×MES; 3×EDO; 2×ACT; 2×FMT;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to mTORC1/2 inhibitor AZ…	7k0d SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1400-1649	1×VQS;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-585	7lb1 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1401-1649	18×EDO; 1×PEG; 1×XWV;
Assess
Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ZS1-322	7t36 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1400-1648	1×EIO; 3×EDO;
Assess
Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ATR kinase inhibit…	7k03 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1399-1646	1×VJM; 4×EDO;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-295	7lb0 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1400-1647	1×XXV; 1×EDO;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ATR inhibitor AZ20	7k27 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1401-1647	4×EDO; 1×VCD; 1×DMS; 1×GOL;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-589	7lb2 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1400-1646	8×EDO; 1×HEZ; 1×XWY;
Assess
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-588	7t2i SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1401-1647	1×DMS; 3×EDO; 1×E9F;
Assess
Crystal structure of the tandem bromodomain of human TAF1 (TAF1-T) bound to ZS1-681	7n42 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1401-1647	7×EDO; 1×06M; 1×DMS;
Assess
Bivalent Inhibitor UNC4512 Bound to the TAF1 Bromodomain Tandem	6fic SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1398-1642	2×DKH;
Assess
TAF1(2) bound to a pyrrolopyridone compound	5i29 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1521-1659	1×67B; 1×CA;
Assess
Second bromodomain of TAF1 bound to a pyrrolopyridone compound	5i1q SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1656	1×67C;
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase inhibitor AZ20	7jjg SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1656	1×VCD; 1×EDO; 1×GOL;
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase inhibitor AZD67…	7jsp SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1656	1×VJM; 1×EDO; 1×SO4;
Assess
Crystal structure of the second bromodomain of human TAF1 in complex with BAY-299 chemical probe	5mg2 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1656	3×EDO; 1×7M8;
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ZS1-580	7lb3 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1656	1×XXS; 1×EDO;
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ZS1-322	7jtc SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1656	1×VK1; 2×EDO;
Assess
BROMODOMAIN OF HUMAN TAF1 (2) WITH naphthyridinone compound	7p4s SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1654	2×5LV;
Assess
TAF1-BD2 bromodomain in complex with (E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]py…	6bqd SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1650	1×69G;
Assess
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to bromosporine	7k1p SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1649	1×BMF; 1×EDO;
Assess
Crystal Structure Analysis of TAF1 Bromodomain	6p39 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1521-1648	1×NQY;
Assess
Crystal Structure Analysis of TAF1 Bromodomain	6p38 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1648	1×NQV;
Assess
Crystal Structure Analysis of TAF1 Bromodomain	6p3a SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1648	1×NQP;
Assess
Crystal Structure of the second bromodomain of human Transcription initiation factor TFIID subunit …	3uv4 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	1522-1644	1×EDO; 1×GOL;
Assess

5 SWISS-MODEL models

Template	Oligo-state	QMEANDisCo	Range	Trg-Tpl Seq id (%)
6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
8og2.1.A	monomer	0.63	1534-1631	29.59
Assess
7egd.1.A	monomer	0.61	362-1263	100.00
Assess
7egb.1.K	monomer	0.57	354-1226	100.00
Assess
7ege.1.A	monomer	0.56	362-1226	100.00
Assess

Model ID	Oligo-state	Avg pLDDT	Range	Trg-Mdl Seq Id (%)

Model ID	Oligo-state	Avg Confidence	Range	Trg-Mdl Seq id (%)

68 SWISS-MODEL models built on isoform sequence

Template	Isoform	Oligo-state	QMEANDisCo	Range	Trg-Tpl Seq id (%)
Isoform 1	6dne.1.A	monomer	0.68	1381-1487	25.11
Assess
Isoform 1	7tv0.1.A	monomer	0.67	1508-1607	29.29
Assess
Isoform 1	7egd.1.A	monomer	0.61	341-1242	100.00
Assess
Isoform 1	7egb.1.K	monomer	0.57	333-1205	100.00
Assess
Isoform 1	7ege.1.A	monomer	0.56	341-1205	100.00
Assess
Isoform 13	6dne.1.A	monomer	0.68	1361-1467	25.11
Assess
Isoform 13	7tv0.1.A	monomer	0.66	1488-1587	29.29
Assess
Isoform 13	7egd.1.A	monomer	0.61	321-1222	100.00
Assess
Isoform 13	7egb.1.K	monomer	0.57	313-1185	100.00
Assess
Isoform 13	7ege.1.A	monomer	0.56	321-1185	100.00
Assess
Isoform 14	6dne.1.A	monomer	0.68	1382-1488	25.11
Assess
Isoform 14	7tv0.1.A	monomer	0.65	1510-1608	29.59
Assess
Isoform 14	7egd.1.A	monomer	0.61	342-1243	100.00
Assess
Isoform 14	7egb.1.K	monomer	0.57	334-1206	100.00
Assess
Isoform 14	7ege.1.A	monomer	0.56	342-1206	100.00
Assess
Isoform 15	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 15	8hag.1.I	monomer	0.61	1532-1630	28.28
Assess
Isoform 15	7egd.1.A	monomer	0.61	362-1263	100.00
Assess
Isoform 15	7egb.1.K	monomer	0.57	354-1226	100.00
Assess
Isoform 15	7ege.1.A	monomer	0.56	362-1226	100.00
Assess
Isoform 16	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 16	8og2.1.A	monomer	0.64	1534-1631	29.59
Assess
Isoform 16	7egd.1.A	monomer	0.61	362-1263	99.50
Assess
Isoform 16	7egb.1.K	monomer	0.57	354-1226	99.50
Assess
Isoform 16	7ege.1.A	monomer	0.56	362-1226	99.50
Assess
Isoform 17	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 17	8og2.1.A	monomer	0.64	1534-1632	30.30
Assess
Isoform 17	7egd.1.A	monomer	0.61	362-1263	100.00
Assess
Isoform 17	7egb.1.K	monomer	0.57	354-1226	100.00
Assess
Isoform 17	7ege.1.A	monomer	0.55	362-1226	100.00
Assess
Isoform 18	7tv0.1.A	monomer	0.69	1529-1628	29.29
Assess
Isoform 18	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 18	7egd.1.A	monomer	0.61	362-1263	99.44
Assess
Isoform 18	7egb.1.K	monomer	0.57	354-1226	99.44
Assess
Isoform 18	7ege.1.A	monomer	0.56	362-1226	99.44
Assess
Isoform 19	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 19	7egd.1.A	monomer	0.61	362-1263	99.94
Assess
Isoform 19	8hak.1.K	monomer	0.60	1532-1630	28.28
Assess
Isoform 19	7egb.1.K	monomer	0.57	354-1226	99.94
Assess
Isoform 19	7ege.1.A	monomer	0.56	362-1226	99.94
Assess
Isoform 20	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 20	7tv0.1.A	monomer	0.67	1529-1628	29.29
Assess
Isoform 20	7egd.1.A	monomer	0.61	362-1263	99.94
Assess
Isoform 20	7egb.1.K	monomer	0.57	354-1226	99.94
Assess
Isoform 20	7ege.1.A	monomer	0.56	362-1226	99.94
Assess
Isoform 21	6dne.1.A	monomer	0.67	1402-1508	25.96
Assess
Isoform 21	7egd.1.A	monomer	0.62	362-1263	99.50
Assess
Isoform 21	6dne.1.A	monomer	0.61	1529-1611	30.49
Assess
Isoform 21	7egb.1.K	monomer	0.57	354-1226	99.50
Assess
Isoform 21	7ege.1.A	monomer	0.56	362-1226	99.50
Assess
Isoform 22	7tv0.1.A	monomer	0.68	1529-1628	29.29
Assess
Isoform 22	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 22	7egd.1.A	monomer	0.62	362-1263	99.44
Assess
Isoform 22	7egb.1.K	monomer	0.57	354-1226	99.44
Assess
Isoform 22	7ege.1.A	monomer	0.56	362-1226	99.44
Assess
Isoform 23	5w0q.1.A	monomer	0.65	1402-1508	18.69
Assess
Isoform 23	7egd.1.A	monomer	0.62	362-1263	100.00
Assess
Isoform 23	7egb.1.K	monomer	0.57	354-1226	100.00
Assess
Isoform 23	7ege.1.A	monomer	0.56	362-1226	100.00
Assess
Isoform 24	4n3w.1.A	monomer	0.64	1404-1509	19.81
Assess
Isoform 24	7egd.1.A	monomer	0.61	362-1263	99.61
Assess
Isoform 24	7egb.1.K	monomer	0.57	354-1226	99.61
Assess
Isoform 24	7ege.1.A	monomer	0.56	362-1226	99.61
Assess
Isoform 25	6dne.1.A	monomer	0.68	1402-1508	25.11
Assess
Isoform 25	7tv0.1.A	monomer	0.67	1529-1628	29.29
Assess
Isoform 25	7egd.1.A	monomer	0.61	362-1263	99.52
Assess
Isoform 25	7egb.1.K	monomer	0.57	354-1226	99.52
Assess
Isoform 25	7ege.1.A	monomer	0.55	362-1226	99.52
Assess

The given sequence checksum does not match our current record for P21675!

P21675 (TAF1_HUMAN) Homo sapiens (Human)

Transcription initiation factor TFIID subunit 1 UniProtKBInterProSTRINGInteractive Modelling

Available Structures

60 Experimental Structures

5 SWISS-MODEL models

68 SWISS-MODEL models built on isoform sequence

Alignments

Background

Resolution

Transcription initiation factor TFIID subunit 1 UniProtKB InterPro STRING Interactive Modelling